MSA Safety’s fair value estimate has been revised from US$212.43 to US$208.14, a trim of about 2% that slightly resets ...
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...
H. Lundbeck A/S (Lundbeck) today announced that new data across its neurology portfolio will be presented at the American Academy of Neurology (AAN) Annual Meeting 2026, taking place April 18–22 in ...
The Boulder Group, a net leased investment brokerage firm, completed the sale of a single tenant new construction Take ...
The 30-year-old company has carved a niche for itself as a tech-enabled service provider to banks with big residential loan ...
New York is facing a dual crisis of energy affordability and bottlenecks to new generation interconnection. The New York Public Service Commission can take action to make affordable technologies ...
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments ...
Arista Networks Inc. (NYSE:ANET) is one of the best US stocks to buy and hold for the next 3 years. On March 12, Arista ...
Fire service industry updates include AI enhancements from Vector Solutions, Pierce's 1,000th delivery of a rig with a PACCAR ...
NCBioImpact, a public/private partnership created to bring together key resources to produce world-class biopharma ...
Galmed announces the breakthrough development of a brain penetrating new formulation of its SCD1 inhibitor, Aramchol: Ramat-Gan, Israel Monday, April 13, 2026, 17:00 Hrs [IST] Gal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results